Aurora M. Fontainhas

Array ( [id] => 13035287 [patent_doc_number] => 10039756 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2018-08-07 [patent_title] => Reducing memory loss in mammals suffering from alzheimer's disease [patent_app_type] => utility [patent_app_number] => 14/901620 [patent_app_country] => US [patent_app_date] => 2014-07-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 10 [patent_figures_cnt] => 10 [patent_no_of_words] => 10494 [patent_no_of_claims] => 8 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 31 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14901620 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 12255304 [patent_doc_number] => 09927445 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2018-03-27 [patent_title] => 'Biomarkers for prediction, diagnosis, and monitoring of parkinson\'s disease' [patent_app_type] => utility [patent_app_number] => 14/325125 [patent_app_country] => US [patent_app_date] => 2014-07-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 2 [patent_no_of_words] => 26029 [patent_no_of_claims] => 4 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 64 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14325125 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 10920318 [patent_doc_number] => 20140323338 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2014-10-30 [patent_title] => 'BIOMARKERS FOR PREDICTION, DIAGNOSIS, AND MONITORING OF ALZHEIMER\'S DISEASE' [patent_app_type] => utility [patent_app_number] => 14/325073 [patent_app_country] => US [patent_app_date] => 2014-07-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 26037 [patent_no_of_claims] => 19 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14325073 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9858666 [patent_doc_number] => 20150038683 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2015-02-05 [patent_title] => 'METHODS AND COMPOSITIONS FOR THE GENERATION AND USE OF CONFORMATION-SPECIFIC ANTIBODIES' [patent_app_type] => utility [patent_app_number] => 14/325013 [patent_app_country] => US [patent_app_date] => 2014-07-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 14489 [patent_no_of_claims] => 1 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14325013 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 10273940 [patent_doc_number] => 20150158937 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2015-06-11 [patent_title] => 'TREATMENT AND PROPHYLAXIS OF AMYLOIDOSIS' [patent_app_type] => utility [patent_app_number] => 14/315040 [patent_app_country] => US [patent_app_date] => 2014-06-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 40 [patent_figures_cnt] => 40 [patent_no_of_words] => 53583 [patent_no_of_claims] => 39 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14315040 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 10792962 [patent_doc_number] => 20160139118 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2016-05-19 [patent_title] => 'NOVEL ASSAY' [patent_app_type] => utility [patent_app_number] => 14/899144 [patent_app_country] => US [patent_app_date] => 2014-06-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 15 [patent_figures_cnt] => 15 [patent_no_of_words] => 9936 [patent_no_of_claims] => 11 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14899144 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 10945822 [patent_doc_number] => 20140348843 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2014-11-27 [patent_title] => 'APOE IMMUNOTHERAPY' [patent_app_type] => utility [patent_app_number] => 14/289546 [patent_app_country] => US [patent_app_date] => 2014-05-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 19525 [patent_no_of_claims] => 27 [patent_no_of_ind_claims] => 12 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14289546 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9757304 [patent_doc_number] => 20140288005 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2014-09-25 [patent_title] => 'COMPOUND FOR TREATMENT OF ALZHEIMER\'S DISEASE AND FAMILIAL DEMENTIA' [patent_app_type] => utility [patent_app_number] => 14/287742 [patent_app_country] => US [patent_app_date] => 2014-05-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 7 [patent_no_of_words] => 11520 [patent_no_of_claims] => 7 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14287742 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9812010 [patent_doc_number] => 20150023956 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2015-01-22 [patent_title] => 'METHODS AND COMPOSITIONS FOR INCREASING ENZYME ACTIVITY IN THE CNS' [patent_app_type] => utility [patent_app_number] => 14/281803 [patent_app_country] => US [patent_app_date] => 2014-05-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 14 [patent_figures_cnt] => 14 [patent_no_of_words] => 33572 [patent_no_of_claims] => 27 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14281803 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 10770332 [patent_doc_number] => 20160116488 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2016-04-28 [patent_title] => 'Method of In Vitro Diagnosis of a Neurological Disorder' [patent_app_type] => utility [patent_app_number] => 14/890993 [patent_app_country] => US [patent_app_date] => 2014-05-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 11626 [patent_no_of_claims] => 15 [patent_no_of_ind_claims] => 10 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14890993 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 10925834 [patent_doc_number] => 20140328856 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2014-11-06 [patent_title] => 'TREATMENT OF ALZHEIMER\'S DISEASE SUBPOPULATIONS WITH POOLED IMMUNOGLOBULIN G' [patent_app_type] => utility [patent_app_number] => 14/270192 [patent_app_country] => US [patent_app_date] => 2014-05-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 62 [patent_figures_cnt] => 62 [patent_no_of_words] => 23219 [patent_no_of_claims] => 33 [patent_no_of_ind_claims] => 10 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14270192 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 10974236 [patent_doc_number] => 20140377271 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2014-12-25 [patent_title] => 'NATURALLY OCCURRING AUTOANTIBODIES AGAINST ALPHA-SYNUCLEIN THAT INHIBIT THE AGGREGATION AND CYTOTOXICITY OF ALPHA-SYNUCLEIN' [patent_app_type] => utility [patent_app_number] => 14/256140 [patent_app_country] => US [patent_app_date] => 2014-04-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 15 [patent_figures_cnt] => 15 [patent_no_of_words] => 16061 [patent_no_of_claims] => 47 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14256140 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 10601263 [patent_doc_number] => 09321817 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2016-04-26 [patent_title] => 'HSP20 inhibits amyloidogenesis and neurotoxicity' [patent_app_type] => utility [patent_app_number] => 14/251709 [patent_app_country] => US [patent_app_date] => 2014-04-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 15 [patent_figures_cnt] => 30 [patent_no_of_words] => 14888 [patent_no_of_claims] => 15 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 34 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14251709 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9785185 [patent_doc_number] => 20140302006 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2014-10-09 [patent_title] => 'SUPPRESSION OF NEUROENDOCRINE DISEASES' [patent_app_type] => utility [patent_app_number] => 14/250959 [patent_app_country] => US [patent_app_date] => 2014-04-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 9 [patent_figures_cnt] => 9 [patent_no_of_words] => 48659 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14250959 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 11481578 [patent_doc_number] => 09588115 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2017-03-07 [patent_title] => 'Method for the diagnosis of neuromyelitis optica' [patent_app_type] => utility [patent_app_number] => 14/780617 [patent_app_country] => US [patent_app_date] => 2014-03-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 4 [patent_no_of_words] => 2922 [patent_no_of_claims] => 3 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 14 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14780617 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 11549685 [patent_doc_number] => 09618524 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2017-04-11 [patent_title] => 'Method, composition, isolation and identification of a plaque particle and related biomarker' [patent_app_type] => utility [patent_app_number] => 14/225788 [patent_app_country] => US [patent_app_date] => 2014-03-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 17 [patent_figures_cnt] => 41 [patent_no_of_words] => 15157 [patent_no_of_claims] => 3 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 101 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14225788 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 10708188 [patent_doc_number] => 20160054335 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2016-02-25 [patent_title] => 'MARKER FOR DIAGNOSING AGE-RELATED MACULAR DEGENERATION, AND METHOD FOR DIAGNOSING AGE-RELATED MACULAR DEGENERATION BY USING SAME' [patent_app_type] => utility [patent_app_number] => 14/779898 [patent_app_country] => US [patent_app_date] => 2014-03-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 9 [patent_figures_cnt] => 9 [patent_no_of_words] => 4458 [patent_no_of_claims] => 13 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14779898 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9670538 [patent_doc_number] => 20140234401 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2014-08-21 [patent_title] => 'METHOD OF TREATING INFLAMMATION USING HUMAN IMMUNOSUPPRESSIVE PROTEIN' [patent_app_type] => utility [patent_app_number] => 14/220714 [patent_app_country] => US [patent_app_date] => 2014-03-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 13340 [patent_no_of_claims] => 4 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14220714 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 10919212 [patent_doc_number] => 20140322231 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2014-10-30 [patent_title] => 'OSTEOPROTEGERIN IN NEUROPROTECTION' [patent_app_type] => utility [patent_app_number] => 14/218507 [patent_app_country] => US [patent_app_date] => 2014-03-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 9 [patent_figures_cnt] => 9 [patent_no_of_words] => 12257 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14218507 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 10684345 [patent_doc_number] => 20160030490 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2016-02-04 [patent_title] => 'PHOTORECEPTORS AND PHOTORECEPTOR PROGENITORS PRODUCED FROM PLURIPOTENT STEM CELLS' [patent_app_type] => utility [patent_app_number] => 14/774771 [patent_app_country] => US [patent_app_date] => 2014-03-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 29 [patent_figures_cnt] => 29 [patent_no_of_words] => 22658 [patent_no_of_claims] => 38 [patent_no_of_ind_claims] => 28 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14774771 [rel_patent_id] =>[rel_patent_doc_number] =>)